Interactions Between Sirolimus and Anti-Inflammatory Drugs: Competitive Binding for Human Serum Albumin.

PURPOSE The aim of the present study was investigating the effects of three anti-inflammatory drugs, on Sirolimus protein biding. The binding site of Sirolimus on human serum albumin (HSA) was also determined. METHODS Six different concentrations of Sirolimus were separately exposed to HSA at pH 7.4 and 37°C. Ultrafiltration method was used for separating free drug; then free drug concentrations were measured by HPLC. Finally, Sirolimus protein binding parameters was calculated using Scatchard plots. The same processes were conducted in the presence of NSAIDs at lower concentration of albumin and different pH conditions. To characterize the binding site of Sirolimus on albumin, the free concentration of warfarin sodium and Diazepam, site I and II specific probes, bound to albumin were measured upon the addition of increasing Sirolimus concentrations. RESULTS Based on the obtained results presence of Diclofenac, Piroxicam and Naproxen, could significantly decrease the percentage of Sirolimus protein binding. The Binding reduction was the most in the presence of Piroxicam. Sirolimus-NSAIDs interactions were increased in higher pH values and also in lower albumin concentrations. Probe displacement study showed that Sirolimus may mainly bind to site I on albumin molecule. CONCLUSION More considerations in co-administration of NSAIDs and Sirolimus is recommended.

• Publication year

  2016

• Venue

  Advanced Pharmaceutical Bulletin

• Publication date

  2016-06-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.15171/apb.2016.031PMID 27478785PMCID PMC4961981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of pH, temperature and protein concentration on the in vitro binding of flutamide to human serum albumin

  2017cited by this paper
• Comparative studies on drug binding to the purified and pharmaceutical-grade human serum albumins: Bridging between basic research and clinical applications of albumin.

  2015cited by this paper
• Spectroscopic study on flavonoid–drug interactions: Competitive binding for human serum albumin between three flavonoid compounds and ticagrelor, a new antiplatelet drug

  2015cited by this paper
• The role of competitive binding to human serum albumin on efavirenz-warfarin interaction: a nuclear magnetic resonance study.

  2013cited by this paper
• Development and application of an HPLC method for erlotinib protein binding studies.

  2013cited by this paper
• Simple RP-HPLC method for estimation of diazepam in tablet dosage form

  2013cited by this paper
• Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin.

  2012cited by this paper
• Development and validation of an HPLC method for the analysis of sirolimus in drug products.

  2012cited by this paper
• Development of a high-performance liquid chromatography method for warfarin detection in human plasma

  2012cited by this paper
• Antibacterial activity of clarithromycin loaded PLGA nanoparticles.

  2012cited by this paper
• Drug–protein binding: a critical review of analytical tools

  2010cited by this paper
• Pharmacokinetics and Comparative Bioavailability Study of Two Clarithromycin Suspensions Following Administration of a Single Oral Dose to Healthy Volunteers

  2009cited by this paper
• Favorable results of concomitant tacrolimus and sirolimus therapy in Taiwanese renal transplant recipients at 12 months.

  2008cited by this paper
• Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration.

  2006cited by this paper
• Monitoring drug-protein interaction.

  2006cited by this paper
• Structural basis of the drug-binding specificity of human serum albumin.

  2005cited by this paper
• Effect of experimental hypoalbuminemia on the plasma protein binding of tolmetin.

  2002cited by this paper
• An immunoassay for the measurement of sirolimus.

  2000cited by this paper
• Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.

  1998cited by this paper
• Mechanism of action of rapamycin (Sirolimus, Rapamune).

  1996cited by this paper
• Mechanism of action of rapamycin (Sirolimus, Rapamune).

  1996cited by this paper
• Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin.

  1993cited by this paper
• Three-dimensional structure of human serum albumin.

  1989cited by this paper

• Considerations for drug–drug interactions between long-acting antiretrovirals and immunosuppressants for solid organ transplantation

  2024cites this paper
• Binding and transport functions of human serum albumin and its clinical implications in liver disease: a narrative review

  2023cites this paper
• Structural Investigation of Diclofenac Binding to Ovine, Caprine, and Leporine Serum Albumins

  2023cites this paper
• Deciphering albumin-directed drug delivery by imaging.

  2022cites this paper
• Study the interactions between multiple flavonoids and bovine serum albumin by the developed equilibrium dialysis.

  2022cites this paper
• Binding affinities of paclitaxel and docetaxel for generic and nanoparticle albumin-bound paclitaxel-derived albumin from human serum.

  2021cites this paper
• Applicability of capillary electrophoresis-frontal analysis for displacement studies: effect of several drugs on L-tryptophan and lidocaine binding to human serum albumin.

  2020cites this paper
• Binding properties of sodium glucose co-transporter-2 inhibitor empagliflozin to human serum albumin: spectroscopic methods and computer simulations

  2020cites this paper
• Sirolimus-Eluting Electrospun-Produced Matrices as Coatings for Vascular Stents: Dependence of Drug Release on Matrix Structure and Composition of the External Environment

  2020cites this paper
• PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer

  2019cites this paper
• Study on the interaction of anti-inflammatory drugs with human serum albumin using molecular docking, quantitative structure-activity relationship, and fluorescence spectroscopy.

  2019cites this paper
• Predicting Protein Binding of Drugs Using AbrahamParameters: Effect of Ionization

  2019cites this paper
• Domain-specific interactions between MLN8237 and human serum albumin estimated by STD and WaterLOGSY NMR, ITC, spectroscopic, and docking techniques

  2017cites this paper
• Characterization of the Effect of Drug-Drug Interaction on Protein Binding in Concurrent Administration of Sulfamethoxazol and Diclofenac Sodium Using Bovine Serum Albumin.

  2016cites this paper